Microba Life Sciences Limited (ASX:MAP)
Australia
· Delayed Price · Currency is AUD 0.0700
+0.0030 (4.48%)
Apr 29, 2026, 4:10 PM AEST
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 40.80 million as of April 28, 2026. Its market cap has decreased by -49.39% in one year.
Market Cap
40.80M
Enterprise Value
32.07M
Revenue
14.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 40.80M, a decrease of -57.51%. That is a compound annual growth rate of -18.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 40.80M | -11.84% |
| Dec 31, 2025 | 46.28M | -47.00% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| INOVIQ | 46.46M |
| Cryosite | 51.25M |
| Genetic Signatures | 32.94M |
| BCAL Diagnostics | 31.34M |
| Rhythm Biosciences | 61.93M |
| Imagion Biosystems | 8.83M |
| Monash IVF Group | 284.43M |
| Genetic Technologies | 5.67M |